Download Text for 2 x Medical Oncology Consultant Posts

LOCUM CONSULTANT IN MEDICAL ONCOLOGY
January 2009
1
1
The Christie NHS Foundation Trust
The Christie l and Holt Radium Institute was founded in 1932 and has grown to be the
largest Cancer Hospital in the UK and one of the largest Cancer Centres in Europe covering a
large population in North West England. The hospital is a designated teaching hospital of
the University of Manchester and is the focal point of the Regional Cancer Network. All
cancer related specialties are fully operational and more than 12,000 new patients with
cancer are seen each year. It is a major Cancer research centre and combined with the
Paterson Institute and University of Manchester comprises the Manchester Cancer Research
Centre.
The Christie is composed of three clinical management divisions:
Networked Services Division – Director, Dr Wendy Makin – includes the Departments of
Medical Oncology, Clinical Oncology, Palliative Care, Paediatric and Adolescent Oncology
Cancer Centre Services – Director, Miss Sarah O’Dwyer - Surgery, Haematology,
Anaesthetics, HDU, Endocrinology
Clinical Support Services – Director, Dr Jeremy Lawrence - Radiology, Pathology. Pharmacy,
Supportive care
Other support services are provided by the Corporate services Division including Finance,
Nursing & Governance, and Estates and Facilities.
Both the Departments of Medical Oncology (Director: Dr Michael Leahy) and Clinical
Oncology (Director: Dr Nick Slevin), have international reputations for their clinical work. All
consultants are site specialised and common treatment policies are developed through the
multi-disciplinary Disease Groups (DGs). Links to the cancer units are maintained through a
number of peripheral and outreach clinics across the network. There are plans for the
Christie to develop satellite centres in the Pennine Trust and in Salford so that ambulatory
care can be can be delivered more locally.
The Christie Hospital NHS Foundation Trust is committed to cancer research. In January
2008, a Research Division was created to take forward this work and further develop
relationships with the University of Manchester, Cancer Research UK, and the Manchester
Cancer Centre. This division is led by Professor John Radford.
A business case has recently been approved by the Board of Directors, to provide a new
building on the Christie site, to provide increased capacity for clinical trials, developing
further the work currently carried out on the Derek Crowther Clincial Trials, unit, provide
increased capacity for service chemotherapy and also provide improved Private Patient
facilities. This work will be complete in early 2010.
A further strategic capital development is the approval by the Christie Board of Directors to
build two satellite radiotherapy centres, at Oldham and Salford.
The present Executive Directors of the Trust are:
Caroline Shaw
Chief Executive
Ian Moston
Director of Finance & Business Development
Dr Chris Harrison
Medical Director
Alison Norman
Director of Nursing & Governance
Roger Spencer
Chief Operating Officer
2
2
Salford Royal NHS Foundation Trust
Salford Royal NHS Foundation Trust was licensed as a Foundation Trust from August 2006. It
is a teaching hospital with 870 beds and provides District Hospital services for Salford. It is
also a sub-regional centre for renal medicine, immunology, neurosciences and neonatal
intensive care and there are many other highly specialised facilities including interventional
radiology, intestinal failure, pain management, dermatology, urology, orthopaedics and
rheumatology.
The Trust is a teaching hospital for the University of Manchester Medical School and has an
established Research and Development programme.
Salford is the site of a major initiative and investment called the ‘SHIFT’ project (Salford
Health Investment For Tomorrow) This project spans primary and secondary care and will
involve novel modes of working and major investment in both primary and secondary care.
On the hospital site this involved a PFI scheme to redevelop facilities.
The Trust is a designated Associate Cancer Centre as outlined in the ‘Harrison’ Strategy for
Greater Manchester, and as such is the identified sector centre for Oesophagogastric,
Urological, Gynaecological and Haematology services. For these services it provides specialist
services for the populations of Ashton, Wigan and Leigh, Bolton and Salford PCT’s. The Trust
hosts the specialist services and MDT’s for Brain and Central Nervous system and Skin
Cancers as well as providing a full range of other local cancers services.
The Trust is working collaboratively with the Christie Trust to develop satellite Radiotherapy
services on the Salford Royal site and to implement the Chemotherapy strategy.
The Trust Board comprised of the Executive Directors of the Trust and is responsible for the
overall performance of the Trust and delivery of its strategic and operational objectives. The
following groups feed into the Trust Board.





Strategy Advisory Group
Clinical effectiveness
Patient and Staff Experience
Risk Management
Finance and Performance
The Trust has a clinical governance strategy, which describes key roles and responsibilities
for staff providing services.
The present Executive Directors of the Trust are
David Dalton
Chief Executive
Dr Stephen Waldek
Medical Director
Tony Whitfield
Director of Finance
Elaine Inglesby
Executive Nurse
Raj Jain
Director of Workforce and Corporate Affairs
Simon Neville
Director of Strategy and Development (and Executive lead
for Cancer)
3
3
The Post
The successful post holder will provide a medical oncology service for Upper GI cancer
patients on Salford Royal and The Christie sites, linking with the existing consultants
specialising in oesophagogastric cancer – Professor Robert Hawkins and Dr Was Mansoor.
The post will combine clinical work at the Christie with work at Salford Royal NHS Foundation
Trust. Currently there are 3 or 4 middle grade doctors (SpRs or ST3 – 6) attached to the GI
team and the post holder will take an equal role with the other GI medical oncology
consultants in supervising these doctors and also the junior grade medical staff in clinic and
on the ward in the care of their patients
Participatient in the Consultant on-call rota (1:16) is optional (attracts a 1% supplement to
the salary)
Expected patient numbers
About 600 new upper GI patients are seen by medical oncologists in the Christie network
and this post is expected to see about a third of these of these (150-200 new patients per
year). These patients will come from Salford Royal NHS Foundation Trust, Wigan, Bolton and
surrounding areas. The remainder of the oesophagogastric cancer practice will be covered by
Dr Was Mansoor (South) Professor Robert Hawkins (North East).
The post holder undertake out patient clinics and provide in patient care. They will work as
part of the multidisciplinary team (MDT) and be a key decision maker in the MDT meetings
held at Salford Royal (Hope Hospital).
The post holder will be expected to partake in supporting professional activities including
audit, teaching and there will be some scope to undertake research. There will be
Supporting Programmed Activities (SPAs) allocated to the post-holder for the above.
4
4
The Cancer Research UK Department of Medical Oncology at The Christie
The CRUK Department of Medical Oncology is now one of the largest departments of cancer
medicine in the UK. Dr Mike Leahy is Director of Medical Oncology and the major remit of
the department is to develop improved methods for cancer patient management. There are
both clinical and laboratory scientific research components that are closely integrated with
clinical research and service work.
The Department is based at the Christie Cancer Centre (Christie Hospital and Paterson
Institute for Cancer Research) with a Breast Cancer Unit at Wythenshawe / Withington
Hospital (University Hospital of South Manchester NHS Foundation Trust) and a Thoracic
Oncology Unit at Wythenshawe Hospital (Cardiothoracic Centre). More than 2,500 new
cancer patients are seen each year by staff in the Department of Medical Oncology.
The Department has links with Preston Oncology Centre and with the Department of Medical
Oncology at Lancaster Royal Infirmary, which is included as part of the Medical Oncology
SpR rotation (total 17 NTN’s).
5
Clinical Staff
There are 17 consultants in the department of Medical Oncology:
Dr Anne Armstrong
Breast
Dr Fiona Blackhall
Lung Cancer
Dr Andrew Clamp
Gynaecology & ovary
Professor Robert Hawkins
Renal, Gastric and Immunotherapy Phase I Trials
Dr Jurjees Hassan
Colorectal and Ovarian
Professor Gordon Jayson
Ovarian Cancer and Anti-Angiogenesis Phase I Trials
Dr Michael Leahy
Sarcoma, Germ Cell Cancer, TYA
Dr Paul Lorigan
Melanoma and Lung Cancer
Dr Was Mansoor
Upper GI
Dr Saifee Mullamitha
Lower GI
Professor John Radford
Lymphoma
Professor Malcolm Ranson
Clinical Pharmacology and Lung Cancer
Professor Nick Thatcher
Lung Cancer
Dr Fiona Thistlethwaite
Upper GI (maternity leave)
Dr Juan Valle
Colorectal, Pancreatic, Cholangiocarcinoma
Dr Andrew Wardley
Breast Cancer
Dr Greg Wilson
Breast and Colorectal Cancer
There are at present ten trainees at Registrar grade and two Specialty Doctors. There are
five ST1-2 level posts. Eight Clinical Research Fellows also participate in clinical activities, in
addition to their laboratory research.
5
6
Associated Departments
6.1 Clinical Oncology (Director Dr Nick Slevin)
Clinical Oncology has 31 consultants and state of the art radiotherapy equipment along with
a major research centre - The Wade Centre (Director Dr John Logue). The Clinical Oncology
Division provides a service to Greater Manchester and North Cheshire through clinics (mainly
weekly) staffed by its consultants in every main town in the area. A good liaison exists
between the divisions of Clinical Oncology and Medical Oncology. Many of the clinical
protocols are run jointly between the two departments and there are excellent opportunities
at Specialist Registrar level to participate in joint teaching programmes.
6.2 Haematological Oncology
Dr James Cavet, Dr Effie Liakopoulou, Dr Adrian Bloor and Dr Mike Dennis run a major
transplant unit with 18 dedicated beds.
6.3 Other Departments
The Department of Histopathology provides a regional cancer service.
The Department of Diagnostic Radiology has two whole body spiral CT scanners and two MR
scanners, in addition to standard radiological and radionuclide imaging facilities. This
department is currently undergoing major refurbishment, and will be re-commissioned with
new and more extensive equipment next year. A PET-CT scanner was installed in early
2008.
The Department of Psychological Medicine is involved in collaborative research projects
concerning psychological assessment and counselling in the context of clinical trials and is
responsible for staff training in aspects of psychological support.
Clinical and Laboratory Scientific Research
A wide range of clinical research studies are in progress. The breast, lung and GI research
groups are major contributors to national and international trials of new treatments. These
include Phase I/II and III chemotherapy studies, combined surgery, radiotherapy and
chemotherapy studies and patient evaluation studies (staging procedures, psychological
assessment etc). A special interest is taken in the development of new biological therapies
particularly anti-angiogenic therapies (lead by Professor Gordon Jayson) and
gene/immunotherapies (led by Professor Robert Hawkins).
These link laboratory research in the Paterson Institute with early phase clinical trials. The
Derek Crowther Unit was opened in 2003 (lead clinician Dr Malcolm Ranson) and provides
excellent clinical research facilities for early phase clinical trials.
Excellent computer facilities are available within the Medical Oncology Division and there is a
close association with the Department of Medical Statistics. Data managers are in post to
help handle clinical and laboratory research data. Training is given in this important aspect
of clinical research.
Administrative facilities
The post holder will have office accommodation with computer, intranet and internet access
at both sites. Similarly there will be secretarial support.
6
7
Further information contacts
Dr M Leahy, Clinical Director, Medical Oncology, Christie
Tel: 0161 446 8384 or e-mail: [email protected]
Dr J Valle, Consultant Medical Oncologist, Medical Oncology, Christie
Tel: 0161 446 8106 or e-mail: [email protected]
Dr F Thistlethwaite, Consultant Medical Oncologist, Medical Oncology, Christie
Tel: 0161 918 7371
or e-mail: [email protected]
7
8
Person Specification
POST: LOCUM CONSULTANT MEDICAL ONCOLOGIST
Upper GI CANCER
REQUIREMENTS
ESSENTIAL
DESIRABLE
Qualifications
MBBS or equivalent
MRCP or equivalent
MD, PHD
Training & Experience
Evidence of wide experience of
general and oncological medicine
An interest in teaching medical,
nursing and allied health
professional staff
Experience of teaching
undergraduate / postgraduate
trainees
Academic / Research
achievements
Personal Skills
Experience of clinical trials in oncology
MSc, MD or PhD
Personal Circumstances
Reliable work record
Good health record
Living within reasonable travelling
distance from the hospital
Good communication skills.
Good people management skills, with
the ability to motivate staff
Demonstrable interpersonal skills
Evidence of good written and oral
English
Flexible approach to work
The ability to work as part of as multidisciplinary team
Good time management skills, with
the ability to handle competing
demands
8